Status:
COMPLETED
Antihypertensive Medications and the Risk of Sepsis
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study was to assess whether there is an increased risk of sepsis with the use of telmisartan compared with other ARBs and with the other major antihypertensive classes, i...
Eligibility Criteria
Inclusion
- \- Patients, 18 years or older, with at least two-year follow-up in United Kingdom's general practice research database (GPRD), who had a diagnosis of or treatment for hypertension
Exclusion
- \- Sepsis, chronic renal failure or on dialysis in the two-year period prior to cohort entry
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1129062 Patients enrolled
Trial Details
Trial ID
NCT02248896
Start Date
January 1 2010
Last Update
September 25 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.